Some Shareholders Feeling Restless Over Amgen Inc.'s (NASDAQ:AMGN) P/E Ratio

When close to half the companies in the United States have price-to-earnings ratios (or "P/E's") below 16x, you may consider Amgen Inc. (NASDAQ:AMGN) as a stock to potentially avoid with its 21.8x P/E

Simply Wall StApr 25 18:33

Why Is Cullinan Therapeutics Stock Trading Higher On Wednesday?

A recent academic case study, published on April 22, examined using Amgen Inc's (NASDAQ:AMGN) Blincyto, a bispecific CD3xCD19 T-cell engager, to treat a patient with severe systemic sclerosis. The fin

BenzingaApr 25 02:29

TikTok to Restrict Weight Loss Drug Promotion

Popular social media platform TikTok is cracking down on most content related to weight loss drugs starting next month, according to the video-sharing site's new community guidelines published last week.

Seeking AlphaApr 23 23:26

Why Amgen (AMGN) Outpaced the Stock Market Today

Yahoo FinanceApr 23 05:50

Goldman's Debt Issuers Stocks Basket

Seeking AlphaApr 23 00:53

10 Best Performing Biotech ETFs in 2024

Yahoo FinanceApr 22 23:10